Therapeutic inertia in type 2 diabetes: prevalence, causes, consequences and methods to overcome inertia
Early glycaemic control leads to better outcomes, including a reduction in long-term macrovascular and microvascular complications. Despite good-quality evidence, glycaemic control has been shown to be inadequate globally. Therapeutic inertia has been shown present in all stages of treatment intensi...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2019-05-01
|
| Series: | Therapeutic Advances in Endocrinology and Metabolism |
| Online Access: | https://doi.org/10.1177/2042018819844694 |
| _version_ | 1819226617136807936 |
|---|---|
| author | Sachin Khunti Kamlesh Khunti Samuel Seidu |
| author_facet | Sachin Khunti Kamlesh Khunti Samuel Seidu |
| author_sort | Sachin Khunti |
| collection | DOAJ |
| description | Early glycaemic control leads to better outcomes, including a reduction in long-term macrovascular and microvascular complications. Despite good-quality evidence, glycaemic control has been shown to be inadequate globally. Therapeutic inertia has been shown present in all stages of treatment intensification, from the first oral antihyperglycaemic drug (OAD), all the way to the initiation of insulin. The causes and possible solutions to the problem of therapeutic inertia are complex but can be understood better when viewed from the perspective of the providers [healthcare professionals (HCPs)], patients and healthcare systems. In this review, we will discuss the possible aetiologies, consequences and solutions of therapeutic inertia, drawing upon evidence from published literature on the subject of type 2 diabetes. |
| first_indexed | 2024-12-23T10:28:20Z |
| format | Article |
| id | doaj.art-809ae836afd74a65b96829e319ad9a15 |
| institution | Directory Open Access Journal |
| issn | 2042-0196 |
| language | English |
| last_indexed | 2024-12-23T10:28:20Z |
| publishDate | 2019-05-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Therapeutic Advances in Endocrinology and Metabolism |
| spelling | doaj.art-809ae836afd74a65b96829e319ad9a152022-12-21T17:50:31ZengSAGE PublishingTherapeutic Advances in Endocrinology and Metabolism2042-01962019-05-011010.1177/2042018819844694Therapeutic inertia in type 2 diabetes: prevalence, causes, consequences and methods to overcome inertiaSachin KhuntiKamlesh KhuntiSamuel SeiduEarly glycaemic control leads to better outcomes, including a reduction in long-term macrovascular and microvascular complications. Despite good-quality evidence, glycaemic control has been shown to be inadequate globally. Therapeutic inertia has been shown present in all stages of treatment intensification, from the first oral antihyperglycaemic drug (OAD), all the way to the initiation of insulin. The causes and possible solutions to the problem of therapeutic inertia are complex but can be understood better when viewed from the perspective of the providers [healthcare professionals (HCPs)], patients and healthcare systems. In this review, we will discuss the possible aetiologies, consequences and solutions of therapeutic inertia, drawing upon evidence from published literature on the subject of type 2 diabetes.https://doi.org/10.1177/2042018819844694 |
| spellingShingle | Sachin Khunti Kamlesh Khunti Samuel Seidu Therapeutic inertia in type 2 diabetes: prevalence, causes, consequences and methods to overcome inertia Therapeutic Advances in Endocrinology and Metabolism |
| title | Therapeutic inertia in type 2 diabetes: prevalence, causes, consequences and methods to overcome inertia |
| title_full | Therapeutic inertia in type 2 diabetes: prevalence, causes, consequences and methods to overcome inertia |
| title_fullStr | Therapeutic inertia in type 2 diabetes: prevalence, causes, consequences and methods to overcome inertia |
| title_full_unstemmed | Therapeutic inertia in type 2 diabetes: prevalence, causes, consequences and methods to overcome inertia |
| title_short | Therapeutic inertia in type 2 diabetes: prevalence, causes, consequences and methods to overcome inertia |
| title_sort | therapeutic inertia in type 2 diabetes prevalence causes consequences and methods to overcome inertia |
| url | https://doi.org/10.1177/2042018819844694 |
| work_keys_str_mv | AT sachinkhunti therapeuticinertiaintype2diabetesprevalencecausesconsequencesandmethodstoovercomeinertia AT kamleshkhunti therapeuticinertiaintype2diabetesprevalencecausesconsequencesandmethodstoovercomeinertia AT samuelseidu therapeuticinertiaintype2diabetesprevalencecausesconsequencesandmethodstoovercomeinertia |